Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Jaguar Health, Inc. (JAGX)

Pharmaceutical Preparations

http://www.jaguar.health

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments-human health and animal health. The company generates the majority of its revenue from the Human Health segment.

200 PINE STREET SUITE 400
SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/13/2015

Market Cap

6,111,538

Shares Outstanding

50,760,000

Weighted SO

50,755,580

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

ONTX --.--%

IBIO --.--%

GOVX --.--%

OCGN --.--%

EFTR --.--%

VIRI --.--%

ZURA --.--%

NAVB --.--%

ZVSA --.--%

Beta

0.8830

Last Div

0.0000

Range

0.95-31.74

Chg

0.0700

Avg Vol

1006510

Mkt Cap

6111538

Exch

NASDAQ

Country

US

Phone

415 371 8300

DCF Diff

0.0941

DCF

-0.0132

Div Yield

0.0000

P/S

0.6001

EV Multiple

-0.8331

P/FV

0.1515

Div Yield %

0.0000

P/E

-0.0823

PEG

-0.0036

Payout

0.0000

Current Ratio

2.0964

Quick Ratio

1.5970

Cash Ratio

0.8388

DSO

48.8817

DIO

913.5516

Op Cycle

962.4333

DPO

391.2899

CCC

571.1433

Gross Margin

0.6251

Op Margin

-3.0815

Pretax Margin

-3.5551

Net Margin

-3.5018

Eff Tax Rate

0.0031

ROA

-0.5803

ROE

-3.5493

ROCE

-0.7415

NI/EBT

0.9850

EBT/EBIT

1.1537

EBIT/Rev

-3.0815

Debt Ratio

0.5425

D/E

1.7196

LT Debt/Cap

0.5294

Total Debt/Cap

0.6323

Int Coverage

-21.3940

CF/Debt

-0.8835

Equity Multi

3.1695

Rec Turnover

7.4670

Pay Turnover

0.9328

Inv Turnover

0.3995

FA Turnover

6.1208

Asset Turnover

0.1657

OCF/Share

-12.5384

FCF/Share

-12.5384

Cash/Share

6.8310

OCF/Sales

-2.8923

FCF/OCF

1.0000

CF Coverage

-0.8835

ST Coverage

-2.5547

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.1515

P/B

0.1515

P/S

0.6001

P/E

-0.0823

P/FCF

-0.2075

P/OCF

-0.0997

P/CF

-0.0997

PEG

-0.0036

P/S

0.6001

EV Multiple

-0.8331

P/FV

0.1515

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation